TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline

George Somlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.